Benzinga··PrnewswireGalmed's Oral Aramchol Breakthrough: 5X Bioavailability Gain Could Transform MASH Treatment
Galmed reports 400mg oral Aramchol meglumine achieves 5-fold greater bioavailability than 300mg free acid, potentially improving compliance and reducing costs by 50%.
GLMDdrug developmentbioavailability
